Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Benjamin Goldenson"'
Autor:
Robert Saddawi-Konefka, Dan Kaufman, Shiqi Tang, Jiyoung Yun, Benjamin Goldenson, Riyam Al-Msari, Davide Bernareggi, Jaya L Thangaraj, Sonam H Patel, Sarah M Luna, J Silvio Gutkind
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 5 (2024)
Background Natural killer (NK) cells are key effector cells of antitumor immunity. However, tumors can acquire resistance programs to escape NK cell-mediated immunosurveillance. Identifying mechanisms that mediate this resistance enables us to define
Externí odkaz:
https://doaj.org/article/94b83004f91d40959f38c9c480b4ef73
Autor:
Maxwell A. Ruby, Benjamin Goldenson, Gabriela Orasanu, Thomas P. Johnston, Jorge Plutzky, Ronald M. Krauss
Publikováno v:
Journal of Lipid Research, Vol 51, Iss 8, Pp 2275-2281 (2010)
Recent evidence suggests that lipoproteins serve as circulating reservoirs of peroxisomal proliferator activated receptor (PPAR) ligands that are accessible through lipolysis. The present study was conducted to determine the biochemical basis of PPAR
Externí odkaz:
https://doaj.org/article/ed87d2e49b4f439dbeebc71875dc5ceb
Publikováno v:
Haematologica, Vol 100, Iss 5 (2015)
GATA1 is a master transcriptional regulator of the differentiation of several related myeloid blood cell types, including erythrocytes and megakaryocytes. Germ-line mutations that cause loss of full length GATA1, but allow for expression of the short
Externí odkaz:
https://doaj.org/article/2039ace4efc8461494dc59c5bd984248
Publikováno v:
Blood. 140:7407-7408
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cb89d6e0efbe2e7f8ac6835cfd98db8
https://doi.org/10.1182/blood-2022-160203
https://doi.org/10.1182/blood-2022-160203
Autor:
Michael Byrne, Tony Kurian, Dilan Patel, Roni Tamari, Sanghee Hong, Haitham Abdelhakim, Victoria Klein, Patricio Rojas, Raksha Madhavan, Andrew Kent, Aaron C. Logan, Catherine J. Lee, Muhammad Husnain, Benjamin Manning, Nicholas Tschernia, Ajoy Dias, Daniel Margalski, Benjamin Goldenson, Nathalie D. Byrne, Heidi Chen, Kseniya Petrova-Drus, Salyka Sengsayadeth, Aaron Goodman, Dianna S. Howard, William A. Wood, Saar Gill, Antonio Jimenez Jimenez, Jonathan A. Gutman, Lohith Gowda, Leland Metheny III, Bhavana Bhatnagar, Betty K. Hamilton, Asmita Mishra, Michael R. Savona
Publikováno v:
Transplantation and Cellular Therapy. 28:S40-S41
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c85e78c730b3cdbaeff91cc19643cea
https://doi.org/10.1016/s2666-6367(22)00207-x
https://doi.org/10.1016/s2666-6367(22)00207-x
Autor:
Xiao-Hua Li, Benjamin Goldenson, Jaya Lakshmi Thangaraj, Matthew Gynn, Diana Gumber, Myan Do, Karl Willert, Dan S. Kaufman
Publikováno v:
Cancer Research. 82:559-559
Switchable chimeric antigen receptors (sCAR) provide an important new strategy to precisely regulate CAR-mediated anti-tumor activity. The sCAR system combines a CAR that recognizes peptide neoepitope (PNE) with an injectable “switch” molecule th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4f3b415660b85eb4d791134a18c24de
https://doi.org/10.1158/1538-7445.am2022-559
https://doi.org/10.1158/1538-7445.am2022-559
Autor:
Jiyoung Yun, Robert Saddawi-Konefka, Benjamin Goldenson, Riyam Al-msari, J Silvio Gutkind, Dan S. Kaufman
Publikováno v:
Cancer Research. 82:2107-2107
Natural killer (NK) cells are a key effector in antitumor immunity. However, tumors often acquire resistance programs to escape NK cell-mediated immunosurveillance. Identifying targetable vulnerabilities that reinvigorate NK cell-driven antitumor imm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aac3408ced93e955395a7ff6462c6c4f
https://doi.org/10.1158/1538-7445.am2022-2107
https://doi.org/10.1158/1538-7445.am2022-2107
Publikováno v:
Cancer Research. 82:553-553
Despite many recent advances, treatment of acute myeloid leukemia (AML) remains challenging. To generate an improved cell-based therapy against AML, our group has produced NK cells from induced pluripotent stem cells (iPSCs). iPSC-derived NK cells ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ee0b103eacc7809a0a9e27f0e6f760e
https://doi.org/10.1158/1538-7445.am2022-553
https://doi.org/10.1158/1538-7445.am2022-553
Publikováno v:
Haematologica. 100:575-584
GATA1 is a master transcriptional regulator of the differentiation of several related myeloid blood cell types, including erythrocytes and megakaryocytes. Germ-line mutations that cause loss of full length GATA1, but allow for expression of the short
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f422d6942e2d76c0105792af2f9d8d9
https://doi.org/10.3324/haematol.2014.112714
https://doi.org/10.3324/haematol.2014.112714
Autor:
John D. Crispino, Benjamin Goldenson
Publikováno v:
Oncogene
The Aurora kinases, which include Aurora A (AURKA), Aurora B (AURKB) and Aurora C (AURKC), are serine/threonine kinases required for the control of mitosis (AURKA and AURKB) and meiosis (AURKC). Since their discovery nearly twenty years ago, Aurora k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef77b4c62085ff3a691c3e2af086fc1b
http://europepmc.org/articles/PMC4167158
http://europepmc.org/articles/PMC4167158